“…For the treatment of experimentally induced tumors mainly lymphokine activated killer (LAK) cells, macrophages, mesenchymal stem cells, and erythrocytes were utilized as drug carriers (Batrakova et al, 2011). Delivered therapeutics include ricin (Cerundolo et al, 1987;Zanovello et al, 1992), doxorubicin and derivatives (Mandruzzato et al, 1994;Zocchi et al, 1989), liposomal 5-fluorouracil (Ikehara et al, 2006), nanoparticulate gold (Kennedy et al, 2011) as well as magnetic nanoparticles (Basel et al, 2012). In addition, genetically modified cells expressing immunotoxins, apoptosis-inducing proteins, and immunomodulating cytokines were tested in cell culture and animal experiments (Pereboeva and Curiel, 2004).…”